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Abstract
Introduction: Lactic acidosis often occurs in severely unwell patients presenting to Accident and
Emergency. It is commonly associated with either hypoxia or decreased tissue perfusion secondary
due to cardiovascular collapse or sepsis.
Case presentation: We present a case of severe lactic acidosis in the presence of normal tissue
perfusion and oxygenation in a 31-year-old patient with poorly-controlled asthma. Acidosis
promptly reversed on discontinuation of inhaled beta-agonists.
Conclusion: Lactic acidosis secondary to inhaled beta-agonist administration may be a common
scenario which can be misinterpreted very easily and can confuse the clinical picture. Further
studies will be needed to establish the exact aetiology of this lactic acid production.
Introduction
Lactic acidosis is diagnosed by a metabolic acidosis, asso-
ciated with an elevated serum lactate concentration. It
often occurs in severely unwell patients presenting to Acci-
dent and Emergency, and is commonly associated with
either hypoxia or decreased tissue perfusion secondary
due to cardiovascular collapse or sepsis. Many drugs may
also result in an increase in serum lactate, including Salb-
utamol.
Case presentation
Ms XF is a 31 year old Caucasian female who has a diag-
nosis of uncontrolled asthma which has required repeated
admissions over approximately ten years [1]. She is other-
wise well with no significant co-morbidities.
Her usual medications are inhaled Salbutamol, Flutica-
sone accuhaler, nebulised Salbutamol, Salmeterol, Mon-
teleucast 10 mg, Theophylline 300 mg bd, Vitamin D3
and Lansoprazole.
The patient was admitted with a history of cough with
green sputum, wheezing and shortness of breath over
three days. Initially she treated herself with Salbutamol
inhalers and nebulised bronchodilators without improve-
ment. She continued to deteriorate and in A&E she was
treated with "back to back" salbutamol nebulisers and
transferred to ITU. On admission she had no evidence of
hypoxia, infection and hypovolemia as evidenced by clin-
ical examination along with invasive monitoring and
investigations such as blood gases, FBC, CRP, and CXR.
In ITU she complained of worsening breathlessness,
despite an objective improvement in peak expiratory flow
rate and wheeze. Her arterial blood gases at that time
showed a compensated metabolic acidosis with high lac-
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tate. We excluded all common causes of a metabolic aci-
dosis in this clinical setting including hypoxia,
hypovolemia and sepsis. We suspected that the lactic aci-
dosis may have been secondary to nebulised salbutamol,
and consequently reduced the dosing interval. This
resulted in a reduction in the serum lactic acid level. When
the nebulised salbutamol was subsequently stopped the
lactic acidosis promptly reversed (Table 1). The patient
was transferred to the ward and discharged home une-
ventfully.
In this particular patient, salbutamol and its resultant
metabolic acidosis caused us difficulty in assessment and
management of her asthma.
Discussion
Salbutamol is a beta agonist associated with a multitude
of systemic side effects. One of the least recognised side
effects of salbutamol with clinical consequence is lactic
acidosis. Lactic acidosis is commonly associated with
either hypoxia or decreased tissue perfusion either due to
cardiovascular collapse or sepsis [2]. There are many views
regarding the pathogenesis of lactic acidosis in asthma;
the most accepted one being due to fatiguing respiratory
muscles [3]. Another accepted explanation could be due
to effects of ischemia and hypoxia on liver which was
unlikely in the above case as this patient had normal liver
function [4].
In healthy volunteers salbutamol will increase the oxygen
consumption by increasing metabolic rate and serum lac-
tate. This will affect patients with severe asthma, who
already limited ventilatory reserve, by increasing their
symptoms [5]. In pregnant patients the lactate levels
increase when given Ritodrine (beta agonist) for tocolysis
[6]. An increase in serum lactate has also been docu-
mented paediatric patients, followed by administration of
nebulised salbutamol [7]. This resolved after the discon-
tinuation of the drug. Lactic acidosis is much more prom-
inent in intravenous salbutamol than nebulised
salbutamol, so intravenous salbutamol should not be
routinely prescribed [8].
Conclusion
In this patient, resolution of wheezing was accomplished
by intensive treatment with salbutamol but at the cost of
lactic acidosis. This was important because acidosis by
itself can result in hyperventilation and a sense of dysp-
noea which could be easily mistaken for failure to
respond to the treatment, as this particular case exempli-
fies. Lactic acidosis secondary to inhaled beta-agonist
administration may be a common scenario which can be
misinterpreted very easily and can confuse the clinical pic-
ture. Further studies will be needed to establish the exact
aetiology of this lactic acid production.
List of abbreviations
FBC – Full Blood count, CRP – C Reactive Protein, CXR –
Chest X-ray, ABG – Arterial Blood Gases, A&E – Accident
and Emergency, ITU – Intensive Treatment Unit, PEFR –
Peak expiratory flow rate, ECG – Electrocardiogram.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
Both author(s) are involved in writing this case report.
Acknowledgements
This patient was consented for publication for this case report.
References
1. Global strategy for asthma management and prevention
2007.  Updated edition Page 11 Figure 4 :3-1.
2. Prakash S, Mehta S: Lactic acidosis in asthma: Report of two
cases and review of the literature Canadian Respiratory
Journal.  2002, 9(3):203-208.
3. Mountain RD, Heffner JE, Brackett NC, Sahn SA: Acid base distur-
bances in acute asthma.  Chest 1900, 98(3):651-655.
Table 1: Arterial blood gas analysis before and after stopping salbutamol. The patient's clinical condition and blood gases improved 
dramatically after cessation of salbutamol. ABGs after 11 hours and 48 hours post-withdrawal of salbutamol are shown.
Time/Date pH PaCO2 PaO2 HCO3 BE Lactate PEFR Symptoms/Treatment
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21.20 hrs
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7.32 3.01 KPa 18.6 KPa 11.7 mmol/l -14 mmol/l 11.06 mmol/l 240 L/min No wheeze, hyperventilation+
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3.00 hrs
7.28 2.29 KPa 11.4 KPa 8.3 mmol/l -19 mmol/l 15.2 mmol/l 230 L/min SOB+++, hyperventilation
12/1/06
7.00 hrs
7.3 2.13 KPa 13.8 KPa 8.0 mmol/l -18 mmol/l 10.09 mmol/l 300 L/min Minimal wheeze Nebulised salbutamol 
discontinued
12/1/06
23.00 hrs
7.43 3.46 KPa 12.3 KPa 17.6 mmol/l -7 mmol/l 6.3 mmol/l 300 L/min No wheeze Continued improvement
14/1/06
10.00 hrs
7.53 3.39 KPa 9.6 KPa 21.0 mmol/l -2 mmol/l 1.1 mmol/l 320 L/min Discharged to ward.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
International Archives of Medicine 2008, 1:3 http://www.intarchmed.com/content/1/1/3
Page 3 of 3
(page number not for citation purposes)
4. Permutt S: Relation between pulmonary arterial pressure and
pleural pressure during the acute asthmatic attack.  Chest
1973, 63(suppl):25S-28S.
5. Tobin AE, Pellizzer A, Santamaria JD: Mechanisms by which sys-
temic salbutamol increases ventilation.  Respirology 2006,
11:182-187.
6. Richards SR, Chang EE, Stempel LE: Hyperlactemia associated
with acute ritodrine infusion.  Am J Obstet Gynecol 1983, 146:1-5.
7. Koul Pulin B, Milan Minarik, Totapally Balagangadhar R: Lactic acido-
sis in children with acute exacerbation of severe asthma.
European Journal of Emergency Medicine 2007, 14(1):56-58.
8. Tobin A: Intravenous salbutamol: too much of a good thing?
[Journal Article].  Crit Care Resusc 2005, 7(2):119-27.